From: Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease
CD4 cell count | Item | Period |  |  |  |  | Average 1–24 months |
---|---|---|---|---|---|---|---|
 | Before ART | 1–6 months | 7–12 months | 13–18 months | 19–24 months | ||
0–50 | Number of patients | 96 | 96 | 95 | 84 | 61 |  |
% hospitalizeda | 14Â % | 22Â % | - | - | - | Â | |
Average days of hospitalizationb | 6 (4–8) | 15 (10–20) | - | - | - | 0.2c | |
Number of outpatient visit | 95 | 47 | 75 | 63 | 41 | 3c | |
% of patients treated for OIa | 2Â % | 63Â % | 27Â % | 18Â % | 8Â % | 29Â % | |
% switched to 2nd line ARVa | - | - | 1Â % | 2Â % | 3Â % | 2Â % | |
Number of CD4 tests | 95 | 47 | 75 | 63 | 41 | 3c | |
Number of viral load tests | - | 6 | 16 | 9 | 4 | 0.4c | |
Number of routine lab tests | 87 | 45 | 74 | 62 | 40 | 3c | |
50–100 | Number of patients | 33 | 33 | 33 | 32 | 25 |  |
% hospitalizeda | 3Â % | 12Â % | - | - | - | Â | |
Average days of hospitalizationb | 3 | 6 (5–7) | - | - | - | 0.2c | |
Number of outpatient visit | 36 | 13 | 29 | 20 | 10 | 2c | |
% of patients treated for OIa | 3Â % | 36Â % | 21Â % | 13Â % | 4Â % | 19Â % | |
% switched to 2nd line ARVa | - | 3Â % | 3Â % | 6Â % | 12Â % | 7Â % | |
Number of CD4 tests | 36 | 13 | 29 | 20 | 10 | 2c | |
Number of viral load tests | - | 5 | 6 | 4 | - | 0.5c | |
Number of routine lab tests | 30 | 14 | 28 | 20 | 9 | 2c | |
100–150 | Number of patients | 22 | 22 | 22 | 18 | 13 |  |
% hospitalizeda | - | 14Â % | - | - | - | Â | |
Average days of hospitalizationb | - | 7 | - | - | - | 0.3c | |
Number of outpatient visit | 29 | 8 | 18 | 13 | 7 | 2c | |
% of patients treated for OIa | - | 45Â % | 18Â % | 11Â % | 15Â % | 22Â % | |
% switched to 2nd line ARVa | - | - | - | - | - | Â | |
Number of CD4 tests | 29 | 8 | 18 | 13 | 7 | 2c | |
Number of viral load tests | 1 | 1 | 4 | 3 | - | 0.4c | |
Number of routine lab tests | 21 | 8 | 17 | 13 | 7 | 2c | |
150–200 | Number of patients | 16 | 16 | 13 | 13 | 11 |  |
% hospitalizeda | 12Â % | 6Â % | - | - | - | Â | |
Average days of hospitalizationb | 5 | 3 | - | - | - | 0.2c | |
Number of outpatient visit | 26 | 9 | 9 | 11 | 7 | 3c | |
% of patients treated for OIa | - | 47Â % | 14Â % | 21Â % | - | 27Â % | |
% switched to 2nd line ARVa | - | - | - | - | - | Â | |
Number of CD4 tests | 26 | 9 | 9 | 11 | 7 | 3c | |
Number of viral load tests | 1 | 4 | 4 | 1 | - | 0.6c | |
Number of routine lab tests | 16 | 8 | 9 | 11 | 7 | 3c | |
>200 | Number of patients | 10 | 10 | 10 | 7 | 4 | Â |
% hospitalizeda | - | - | - | - | - | Â | |
Average days of hospitalizationb | - | - | - | - | - | Â | |
Number of outpatient visit | 17 | 5 | 6 | 4 | 4 | 3c | |
% of patients treated for OIa | - | 10Â % | - | - | - | 10Â % | |
% switched to 2nd line ARVa | - | - | - | - | - | Â | |
Number of CD4 tests | 17 | 5 | 6 | 4 | 4 | 3c | |
Number of viral load tests | - | - | - | - | - | Â | |
Number of routine lab tests | 9 | 5 | 6 | 4 | 4 | 3c |